Leptomeningeal carcinomatosis originating from gastric cancer: Report of eight cases and review of the literature

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 2, 2003, Pages 165-170

  Lisenko, Yulia ^a   Kumar, Ashok J ^a   Yao, James ^a   Ajani, Jaffer ^a   Ho, Linus ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinomatosis; Gastric cancer; Leptomeningeal disease

Indexed keywords

CISPLATIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MAFOSFAMIDE; METHOTREXATE; PACLITAXEL;

ADULT; CANCER CHEMOTHERAPY; CARCINOMATOUS MENINGITIS; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; REVIEW; SIGNET RING CARCINOMA; STOMACH CANCER; SURVIVAL TIME; SYMPTOMATOLOGY; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037391250     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200304000-00013     Document Type: Review

References (20)

1. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759-72.
2. Tsujikawa T, Tsukamoto H, Itoh A, et al. Meningitis carcinomatosa originating from an alpha fetoprotein-producing gastric cancer. Intern Med 2000;39:223-7.
3. Chamberlain MC, Kormanik PA, Barba D. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 1997;87:694-9.
4. Iwa N, Yutani C, Kobayashi TK. Immunocytochemical localization of carcinoembryonic antigen in cerebrospinal fluid with metastatic carcinoma of the stomach: report of four cases. Diagn Cytopathol 1988;4:312-5.
5. Sze G, Soletsky S, Bronen R, et al. MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. AJNR Am J Neuroradiol 1989;10:965-75.
6. Straathof CS, de Bruin HG, Dippel DW, et al. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 1999;246:810-4.
7. Fouladi M, Gajjar A, Boyett JM, et al. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 1999;17:3234-7.
8. Enzmann DR, Krikorian J, Yorke C, et al. Computed tomography in leptomeningeal spread of tumor. J Comput Assist Tomogr 1978;2:448-55.
9. Fisher MA, Weiss RB. Carcinomatous meningitis in gastrointestinal malignancies. South Med J 1979;72:930-2.
10. Haba T, Kitoh C, Takeshita H, et al. [Case of gastric cancer associated with acanthosis nigricans and meningeal carcinomatosis]. Gan No Rinsho 1983;29:927-30.
11. Usui N, Ogawa M, Inagaki J, et al. [Case report of meningeal carcinomatosis of gastric cancer successfully treated with intrathecal and systemic chemotherapy]. Gan To Kagaku Ryoho 1985;12:155-9.
12. Otsuji E, Yamaguchi T, Sawai K, et al. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma. Am J Gastroenterol 1999;94:434-7.
13. Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999;5:1823-9.
14. Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 2001;37:918-23.
15. Kurozumi K, Nishida T, Nakao K, et al. Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer. World J Surg 1998;22:853-8.
16. Saito H, Tsujitani S, Katano K, et al. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Cancer 1998;83:1094-101.
17. MacDonald JS, Schein PS, Woolley PV, et al. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980;93:533-6.
18. Kohne CH, Wils JA, Wilke HJ, Developments in the treatment of gastric cancer in Europe, Oncology (Huntingt) 2000;14(suppl 14):22-5.
19. Tas F, Aykan NF, Aydiner A, et al. The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival. Am J Clin Oncol 2000;23:53-7.
20. Hansson LE, Sparen P, Nyren O. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg 1999;230:162-9.